Andrew Brooks
Andrew Ira Brooks (February 10, 1969 – January 23, 2021) was an American immunologist, academic, and businessman. He was an associate research professor at Rutgers University. He created the first FDA-approved rapid saliva test for COVID-19 diagnosis.[1]
Andrew I. Brooks | |
|---|---|
| Born | February 10, 1969 Bronxville, New York, U.S. |
| Died | January 23, 2021 (aged 51) New York City, U.S. |
| Education | |
| Known for |
|
| Children | 3 |
| Scientific career | |
| Fields | Molecular neuroscience |
| Institutions |
|
Brooks died on January 23, 2021 from a heart attack in New York City, aged 51.[2]
References
- ↑ Buccino, Neal (January 26, 2021). "Mourning the Death of Rutgers' Andrew Brooks, a Leader in the Fight Against COVID-19". Rutgers.edu. Archived from the original on January 26, 2021. Retrieved February 1, 2021.
- ↑ Snyder, Alec (January 31, 2021). "Andrew Brooks, who led development of the first FDA-approved Covid-19 saliva test, dies at 51". CNN. Archived from the original on February 1, 2021. Retrieved February 1, 2021.
This short article about a person from the United States can be made longer. You can help Wikipedia by adding to it.